Curated Wealth Partners 13F: Cuts CME Stake by $172M

An institutional filing shows Curated Wealth Partners sold off nearly its entire stake in exchange operator CME Group Inc.

Reviewed by automated data checks against the source filing. How we make and check alerts

Curated Wealth Partners sold 657,472 shares from its stake in CME Group Inc. ($CME), a 99.82% decrease, according to a 13F filing with the SEC dated October 15, 2026. It reported 1,163 shares worth $304,684 at the end of the quarter.

Since the filing, $CME is up 1.5% to date (from the $289.46 close on Oct 15, 2026).

Find the original: Curated Wealth Partners 13F filings on SEC EDGAR

CME CME Group Inc.
$293.87 +12.68% year to date
Daily close · Oct 16, 2026

Key Points

  • Curated Wealth Partners cut its holdings in CME Group Inc. by 99.8%, selling 657,472 shares to leave a remaining stake of 1,163 shares.
  • CME Group shares recently traded around $290.33, sitting above both their 50-day and 200-day moving averages as earnings approach.
  • Major financial institutions adjusted their positions recently, with Blackrock Inc. trimming shares while Vanguard Capital Management added to its stake.

Get $CME trade alerts by text

We text you when insiders, Congress or big funds trade $CME. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures

Curated Wealth Partners made a sharp move away from CME Group Inc. CME by shedding nearly all of its investment, according to a recent Form 13F filing with the SEC. Institutional 13F filings look backward at holdings from the end of a specific quarter, meaning these transactions may not reflect the investor's current portfolio today.

Inside Curated Wealth Partners's CME Group Inc. Trade

In the filing on October 15, 2026, Curated Wealth Partners reported cutting its stake by a dramatic 99.8%. The fund got rid of 657,472 shares during the period, leaving it with a tiny remaining holding of 1,163 shares valued at about $304,684. This aggressive reduction scales back what was previously a much larger position of 658,635 shares.

Other Institutional Activity in CME Group Inc.

Other major asset managers made their own adjustments to CME Group holdings around the same time. Blackrock Inc. grew its holdings by reducing shares by 880,512, ending with 30,566,342 shares worth about $8,982,530,774. Vanguard Capital Management LLC grew its holdings by 294,430 shares, ending with 23,661,856 shares worth about $6,953,509,507. State Street Corporation grew its holdings by 290,606 shares, ending with 16,346,170 shares worth about $4,803,648,898. Morgan Stanley grew its holdings by 321,702 shares, ending with 9,728,195 shares worth about $2,858,824,617. Geode Capital Management, LLC grew its holdings by 124,398 shares, ending with 9,271,309 shares worth about $2,724,559,530.

CME Group Inc. Stock Up 0.3%

CME Group shares recently traded around $290.33 as of October 16, 2026. The stock sits about 6.3% above its 50-day moving average of $273.17 and about 4.2% above its 200-day moving average of $278.60. Shares remain about 11.8% below their 52-week high of $329.16 while trading well above the 52-week low of $218.31.

Recent Earnings

CME Group reported trailing-twelve-month revenue of $6,757,199,872 alongside basic earnings of $11.79 per share. The company operates with a net profit margin of 63.4% and a return on equity of 15.8%. The next corporate earnings update is scheduled for October 21, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 28/100

Reported Apr 22, 2026

  1. Forward outlook

    2 target cuts vs 0 raises.

  2. EPS & revenue

    EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.

  3. Profit surprise

    EBITDA missed by 6 percent. Operating income missed by 5 percent.

  4. Pre-earnings setup

    Expectations were about average.

  5. Analyst signal

    2 target cuts.

  6. Earnings quality

    Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.

Earnings Call Summary

CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.

Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Dividend

CME Group pays an annual dividend rate of $5.20 per share, giving the stock a dividend yield of 1.8%. The company pays out 95.4% of its earnings as dividends.

Insider Buying and Selling at CME Group Inc.

Company insiders executed several stock purchases earlier in the year. On June 25, 2026, insider Timothy Bitsberger bought 645 shares at an average price of $225.00 for a total value of $145,125. On the same day, Daniel Kaye bought 645 shares at $225.00 worth $145,125. Ford Harold Eugene JR. picked up 1,067 shares at $225.00 totaling $240,075, and Tierney Robert JR acquired 645 shares at $225.00 worth $145,125. None of these transactions were made under a pre-arranged Rule 10b5-1 plan.

Analysts Set New Price Targets

Wall Street analysts have updated their outlooks ahead of the company's next earnings report. On October 5, 2026, UBS maintained its Neutral rating while raising its price target to $270.00 from $260.00. On the same day, TD Cowen maintained a Buy rating and lifted its target to $300.00 from $292.00. Barclays maintained an Equal-Weight rating with a $281.00 target on October 7, 2026. Morgan Stanley kept an Overweight rating and raised its target to $337.00 on October 9, 2026. Finally, Wells Fargo maintained an Overweight rating on October 14, 2026, moving its target to $315.00 from $301.00. Across 16 analyst opinions, the stock carries a consensus hold rating with a mean price target of $292.94.

About CME Group Inc.

CME Group operates major global financial exchanges where market participants trade futures and options contracts. The Chicago-based firm handles products tied to interest rates, agricultural goods, foreign exchange, energy, and stock indexes, serving as a key infrastructure provider for global risk management.

Bottom Line

Investors will look closely at CME Group's upcoming earnings report on October 21, 2026, to gauge ongoing revenue growth and trading volumes. Institutional reports like Curated Wealth Partners's recent filing show historical positioning, and future updates will reveal how other large holders adjust their stakes. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.

Source: Curated Wealth Partners's 13F filing on $CME (Oct 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Curated Wealth Partners 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $CME trade alerts by text